Outlook Therapeutics Logo

Outlook Therapeutics

NASDAQ: OTLK
Nasdaq Stock Market NYSE
Healthcare Biotechnology
Global Rank
#25831
Country Rank
#3668
Market Cap
81.42 M
Price
1.9
Change (%)
1.60%
Volume
664,314

Outlook Therapeutics (NASDAQ: OTLK) Stock Split History

This company has undergone a total of two stock splits throughout its history. Two reverse splits occurred, consolidating shares and stabilizing stock prices. The most recent split occurred on 03/14/2024 with a ratio of 1-for-20. These adjustments reflect the company's strategic efforts to align stock performance with market conditions.
Date Split Ratio Multiple Cumulative multiple Type
03/14/2024 1:20 x0.05 x0.00625 Reverse
03/18/2019 1:8 x0.125 x0.125 Reverse

Frequently Asked Questions

  • How much would Outlook Therapeutics stock be worth if it never split?
    If Outlook Therapeutics (stock symbol: NASDAQ: OTLK) had never undergone any stock splits, its price per share today would be approximately 0.01 USD. This calculation reflects the cumulative effect of all splits, including the most recent split (ratio: 1-for-20) that occurred on 03/14/2024.
  • Outlook Therapeutics (stock symbol: NASDAQ: OTLK) has undergone a total of two stock splits. The most recent split occurred on 03/14/2024. One share bought prior to the first split on 03/18/2019 would now equal 0.01 shares.
  • Outlook Therapeutics (stock symbol: NASDAQ: OTLK) has undergone two stock splits in its history. The most recent split, a 1-for-8 split, occurred on 03/14/2024. While future splits are not guaranteed, significant increases in stock price could prompt consideration for another split.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking
Community

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.